Involvement of Nonreceptor Protein Tyrosine Kinases in Multichain Immune Recognition Receptor Signal Transduction

  • Anne L. Burkhardt
  • Sandra J. Saouaf
  • Sandeep Mahajan
  • Joseph B. Bolen
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 365)


The nonreceptor protein tyrosine kinases (PTKs) represent cellular enzymes grouped together based upon their lack of defined extracellular sequences. The currently identified nonreceptor PTKs can be divided into nine different enzyme groups based upon predicted structural features. With the exception of the Focal Adhesion Kinase (Fak) and the Activated Cdc42Hs-associated Kinase (Ack) which are the only known members of these two individual PTK groups, the remaining PTKs appear to be members of distinct PTK families. They range in size from about 50 kDa for the C-src Kinase (Csk) family to approximately 150 kDa for the Abl kinase family. All of these PTKs are likely to be involved in one or more signaling pathways that modulate growth, differentiation, and mature cell function.


Focal Adhesion Kinase Cytoplasmic Domain Cell Antigen Receptor Tyrosine Autophosphorylation Nonreceptor Protein Tyrosine Kinase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    S.K. Hanks, A.M. Quinn, and T. Hunter, The protein kinase family: conserved features and deduced phylogeny of the catalytic domains, Science, 241:42–52, (1988).PubMedCrossRefGoogle Scholar
  2. 2.
    A.F. Wilks, A.G. Harpur, R.R. Kurban, S.J. Ralph, G. Zurcher, and A. Ziemmeicki, Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase, Mol. Cell. Biol., 11:2057–2065, (1991).PubMedGoogle Scholar
  3. 3.
    S. Nada, M. Okada, A. MacAuley, J.A. Cooper, and H. Nakagawa, Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src, Nature, 351:69–72, (1991).PubMedCrossRefGoogle Scholar
  4. 4.
    S. Klages, D. Adam, K. Class, J. Fargnoli, J.B. Bolen, and R.C. Penhallow, Ctk: a novel protein tyrosine kinase related to Csk that defines a new enzyme family, Proc. Natl. Acad. Sci. U.S.A., 91:2597–2601 (1994).PubMedCrossRefGoogle Scholar
  5. 5.
    A.C. Chan, M. Iwashima, C.W. Turck, and A. Weiss., ZAP-70: a 70-kD protein tyrosine kinase that associates with the TCR ζchain, Cell, 71:649–662, (1992).PubMedCrossRefGoogle Scholar
  6. 6.
    T. Pawson, and G.D. Gish, SH2 and SH3 domains: from structure to function, Cell, 71:359–362, (1992).PubMedCrossRefGoogle Scholar
  7. 7.
    B.J. Mayer, and D. Baltimore, Signaling through SH2 and SH3 domains. Trends in Cell Biol., 3:8–13, (1993).CrossRefGoogle Scholar
  8. 8.
    E. Manser, T. Leung, H. Salihuddin, L. Tan, and L. Lim, A non-receptor tyrosine kinase that inhibits the GTPase activity of p21cdc42, Nature, 363:364–367 (1993).PubMedCrossRefGoogle Scholar
  9. 9.
    Z. Songyang, S.E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W.G. Haser, F. King, T. Roberts, S. Tarnofsky, R.J. Lechleider, B.G. Neel, R.B. Birge, J.E. Fajardo, M.M. Chou, H. Hanafusa, B. Schaffhausen, and L.C. Cantley, SH2 domains recognize specific phosphopeptide sequences, Cell, 72:767–778 (1993).PubMedCrossRefGoogle Scholar
  10. 10.
    C.A. Koch, D. Anderson, M.F. Moran, C. Ellis, and T. Pawson, SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins, Science, 252:668–674, (1991).PubMedCrossRefGoogle Scholar
  11. 11.
    R. Ren, B.J. Mayer, P. Cicchetti, and D. Baltimore. Identification of a ten amino acid proline rich SH3 binding site, Science, 259:1157–1161, (1993).PubMedCrossRefGoogle Scholar
  12. 12.
    G. Waksman, D. Kominos, S.C. Robertson, N. Pant, D. Baltimore, R.B. Birge, D. Cowburn, H. Hanafusa, B.J. Mayer, M. Overduin, M.D. Resh, C.B. Rios, L. Silverman, and J. Kuriyan, Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides, Nature 358: 646–653, (1992).PubMedCrossRefGoogle Scholar
  13. 13.
    M. Overduin, B. Mayer, C.B. Rios, D. Baltimore, and D. Cowburn, Secondary structure of src homology 2 domain of c-Abl by heteronuclear NMR spectroscopy in solution, Proc. Natl. Acad. Sci. U.S.A. 89:11673–11677, (1992).PubMedCrossRefGoogle Scholar
  14. 14.
    G.W. Booker, A.L. Breeze, A.K. Downing, G. Panayatou, I. Gout, M.D. Waterfield, and I.D. Campbell, Structure of an SH2 domain of the p85a subunit of phosphatidylinositol-3-OH kinase, Nature, 358:684–687, (1992).PubMedCrossRefGoogle Scholar
  15. 15.
    A. Musacchio, M. Noble, R. Paulpitt, R. Wierenga, and M. Saraste, Crystal structure of a Src-homology 3 (SH3) domain, Nature, 359:851–855, (1992).PubMedCrossRefGoogle Scholar
  16. 16.
    H. Yu, M.K. Rosen, T.B. Shin, C. Seidel-Dugan, J.S. Brugge, and S.L. Schreiber, Solution structure of the SH3 domain of Src and identification of its ligand-binding site, Science, 258:1665–1668, (1992).PubMedCrossRefGoogle Scholar
  17. 17.
    M.J. Eck, S.E. Shoelson, and S.C. Harrison, Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck, Nature, 362:87–91, (1993).PubMedCrossRefGoogle Scholar
  18. 18.
    G. Waksman, S.E. Shoelson, N. Pant, D. Cowburn, and J. Kuriyan, Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms, Cell, 72:779–790, (1993).PubMedCrossRefGoogle Scholar
  19. 19.
    J.E. Buss, M.P. Kamps, and B.M. Sefton, Myristic acid is attached to the transforming protein of Rous sarcoma virus during or immediately after synthesis and is present in both soluble and membrane-bound forms of the protein, Mol. Cell. Biol. 4:2697–2704, (1984).PubMedGoogle Scholar
  20. 20.
    M.P. Kamps, J.E. Buss, and B.M. Sefton, Mutation of NH2-terminal glycine of p60src prevents both myristylation and morphological transformation, Proc. Natl. Acad. Sci. U.S.A., 82:4625–4628, (1985).PubMedCrossRefGoogle Scholar
  21. 21.
    P. Jackson, and D. Baltimore, N-terminal mutations activate the leukemogenic potential of the myristolated form of c-Abl, EMBOJ., 8:449–456, (1989).Google Scholar
  22. 22.
    G.Q. Daley, R.A. Van Etten, P. Jackson, A. Bernards, and D. Baltimore, Nonmyristolated Abl proteins transform a factor-dependent hematopoietic cell line, Mol. Cell. Biol. 12:1864–1871, (1992).PubMedGoogle Scholar
  23. 23.
    M.D. Resh, Membrane interactions of pp60v-src: a model for myristylated tyrosine protein kinases, Oncogene, 5:1437–1444, (1990).PubMedGoogle Scholar
  24. 24.
    LA. Paige, M.J.S. Nadley, M.L. Harrison, J.M. Cassady, and R.L. Geahlen, Reversible palmitylation of the protein tyrosine kinase p56lck, J. Biol. Chem. 268: 8669–8674, (1993).PubMedGoogle Scholar
  25. 25.
    A.M. Shenoy-Scaria, J. Kwong, T. Fujita, M.W. Olszowy, A.S. Shaw, and D.M. Lublin, Signal transduction through decay-accelerating factor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p56lck and p59fyn, J. Immunol. 149: 3535–3541 (1992).PubMedGoogle Scholar
  26. 26.
    P.M. Thomas, and L.E. Samelson, The glycophosphatidylinositol-anchored Thy-1 molecule interacts with the p60fyn protein tyrosine kinase. J. Biol. Chem. 267: 12317–12322, (1992).PubMedGoogle Scholar
  27. 27.
    A.M. Shenoy-Scaria, L.K. Timson Gauen, J. Kwong, A.S. Shaw, and D.M. Lublin, Palmitylation of an amino-terminal cysteine motif of protein tyrosine kinases p56lck and p59fyn mediates interaction with glycosyl-phosphatidylinositol-anchored proteins, Mol. Cell. Biol. 13: 6385–6392, (1993).PubMedGoogle Scholar
  28. 28.
    M. Reth, Antigen receptor tail clue, Nature, 338:383, (1989).PubMedCrossRefGoogle Scholar
  29. 29.
    L.E. Samelson, and R.D. Klausner, Tyrosine kinases and tyrosine-based activation motifs — current research on activation via the T cell antigen receptor, J. Biol. Chem. 267:24913–24916, (1992).PubMedGoogle Scholar
  30. 30.
    A. Weiss, T cell antigen receptor signal transduction: a tale of tails and cytoplasmic protein-tyrosine kinases, Cell, 73:209–212, (1993).PubMedCrossRefGoogle Scholar
  31. 31.
    J.C. Cambier, and K.S. Campbell, Membrane immunoglobulin and its accomplices: new lessons from an old receptor, FASEB J., 6:3207–3217, (1992).PubMedGoogle Scholar
  32. 32.
    F. Letourner, and R.D. Klausner, Activation of T cells by a tyrosine kinase activation domain in the cytoplasmic tail of CD3 ε, Science, 255:79–82, (1992).CrossRefGoogle Scholar
  33. 33.
    K.M. Kim, G. Alber, P. Weiser, and M. Reth, Differential signaling through the Igα and Igβ components of the B cell antigen receptor, Eur.J. Immunol, 132:125–146, (1993).Google Scholar
  34. 34.
    M. Sanchez, Z. Misulovin, A.L. Burkhardt, S. Mahajan, T. Costa, R. Franke, J.B. Bolen, and M. Nussenzweig, Signal transduction by immunoglobulin is mediated through Igα and Igβ, J. Exp. Med., 178:1049–1055, (1993).PubMedCrossRefGoogle Scholar
  35. 35.
    B.A. Irving, A.C. Chan, and A. Weiss, Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain, J. Exp. Med., 177:1093–1103, (1993).PubMedCrossRefGoogle Scholar
  36. 36.
    F. Letourner, and R.D. Klausner, T-cell and basophil activation through the cytoplasmic domain of T cell receptor ζ family members, Proc. Natl. Acad. Sci. U.S.A., 88:8905–8909, (1991).CrossRefGoogle Scholar
  37. 37.
    A.L. Burkhardt, T. Costa, Z. Misulovin, B. Stealey, J.B. Bolen, and M.C. Nussenzweig, Iga and Igβ are functionally homologous to the signaling proteins of the T-cell receptor, Mol. Cell. Biol., 14:1095–1103,(1994).PubMedGoogle Scholar
  38. 38.
    C. Romeo, M. Amiot, and B. Seed, Sequence requirements for the induction of cytolysis by the T cell antigen/Fc receptor ζ chain, Cell, 68:889–897, (1992).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Anne L. Burkhardt
    • 1
  • Sandra J. Saouaf
    • 1
  • Sandeep Mahajan
    • 1
  • Joseph B. Bolen
    • 1
  1. 1.Department of Molecular BiologyBristol-Myers Squibb Pharmaceutical Research InstitutePrincetonUSA

Personalised recommendations